Longvert C - Search Results

1

Increase in NRAS mutant allele percentage during metastatic melanoma progression.

Funck-Brentano E, Hélias-Rodzewicz Z, Longvert C, Mokhtari K, Saiag P, Emile JF. Funck-Brentano E, et al. Among authors: longvert c. Exp Dermatol. 2016 Jun;25(6):472-4. doi: 10.1111/exd.13001. Epub 2016 May 18. Exp Dermatol. 2016. PMID: 26990546

2

[Ulcerations or erosion of the oral and/or genital mucosae].

Mahé E, Longvert C, Saiag P. Mahé E, et al. Among authors: longvert c. Rev Prat. 2006 Mar 31;56(6):667-72. Rev Prat. 2006. PMID: 16705928 French. No abstract available.

3

The contribution of high-resolution ultrasonography in preoperatively detecting sentinel-node metastases in melanoma patients.

Sibon C, Chagnon S, Tchakérian A, Bafounta ML, Longvert C, Clerici T, Zimmermann U, Saiag P. Sibon C, et al. Among authors: longvert c. Melanoma Res. 2007 Aug;17(4):233-7. doi: 10.1097/CMR.0b013e3282c3a65a. Melanoma Res. 2007. PMID: 17625453

4

Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.

Moreau S, Saiag P, Aegerter P, Bosset D, Longvert C, Hélias-Rodzewicz Z, Marin C, Peschaud F, Chagnon S, Zimmermann U, Clerici T, Emile JF. Moreau S, et al. Among authors: longvert c. Ann Surg Oncol. 2012 Dec;19(13):4314-21. doi: 10.1245/s10434-012-2457-5. Epub 2012 Jul 7. Ann Surg Oncol. 2012. PMID: 22772867 Clinical Trial.

5

[In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].

Elfatoiki FZ, Longvert C, Clerici T, Bourgault-Villada I, Roudier-Pujol C, Vasseur E, Saiag P. Elfatoiki FZ, et al. Among authors: longvert c. Ann Dermatol Venereol. 2014 Feb;141(2):106-10. doi: 10.1016/j.annder.2013.10.058. Epub 2014 Jan 14. Ann Dermatol Venereol. 2014. PMID: 24507204 French.

6

Uveitis in patients with late-stage cutaneous melanoma treated with vemurafenib.

Guedj M, Quéant A, Funck-Brentano E, Kramkimel N, Lellouch J, Monnet D, Longvert C, Gantzer A, Brézin AP. Guedj M, et al. Among authors: longvert c. JAMA Ophthalmol. 2014 Dec;132(12):1421-5. doi: 10.1001/jamaophthalmol.2014.3024. JAMA Ophthalmol. 2014. PMID: 25125216

7

Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance.

Funck-Brentano E, Alvarez JC, Longvert C, Abe E, Beauchet A, Funck-Brentano C, Saiag P. Funck-Brentano E, et al. Among authors: longvert c. Ann Oncol. 2015 Jul;26(7):1470-5. doi: 10.1093/annonc/mdv189. Epub 2015 Apr 21. Ann Oncol. 2015. PMID: 25899783 Free article.

8

Relapsing pneumonitis due to two distinct inhibitors of the MAPK/ERK pathway: report of a case.

Giraud V, Longvert C, Houlle-Crepin S, Danel C, Labrune S, Camus P, Saiag P, Chinet T. Giraud V, et al. Among authors: longvert c. BMC Cancer. 2015 Oct 19;15:732. doi: 10.1186/s12885-015-1754-3. BMC Cancer. 2015. PMID: 26481107 Free PMC article.

9

Reply to the letter to the editor 'Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumor response and tolerance' by Funck-Brentano et al.

Funck-Brentano E, Alvarez JC, Longvert C, Abe E, Beauchet A, Saiag P, Funck-Brentano C. Funck-Brentano E, et al. Among authors: longvert c. Ann Oncol. 2016 Feb;27(2):364-5. doi: 10.1093/annonc/mdv549. Epub 2015 Nov 16. Ann Oncol. 2016. PMID: 26578725 Free article. No abstract available.

10

On/off dropped head syndrome: A severe adverse event after prolonged treatment with MEK inhibitor.

Longvert C, Maisonobe T, Saiag P, Auré K. Longvert C, et al. Eur J Cancer. 2018 Mar;91:174-176. doi: 10.1016/j.ejca.2017.11.027. Epub 2017 Dec 15. Eur J Cancer. 2018. PMID: 29254632 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters